FDA approved an updated version of MarginProbe, a medical device that enables real-time detection of cancer at the surface of excised tissue specimens during breast-conserving cancer surgery. MarginProbe is developed by Dune Medical Devices.
Surgeon feedback, design ideas and miniaturization engineering were the driving forces behind the development of MarginProbe 1.2, according to Dune. The new version uses the same diagnostic technology as version 1.1, improving functionality, portability and overall ease of use, including a smaller size and a brighter screen.
